The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Bristol-Myers Squibb to Take Part in Leerink Swann Global Health Care Conference

Wednesday, February 06, 2013

Bristol-Myers Squibb to Take Part in Leerink Swann Global Health Care Conference14:02 EST Wednesday, February 06, 2013 NEW YORK (Business Wire) -- Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Leerink Swann 2013 Global Health Care Conference on Wednesday, February 13, 2013, in New York. Charles Bancroft, executive vice president and chief financial officer, will answer questions about the company at 3:30 p.m. EST. Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day. About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews. Bristol-Myers Squibb CompanyMedia:Jennifer Fron Mauer, 609-252-6579jennifer.mauer@bms.comorInvestors:John Elicker, 609-252-4611john.elicker@bms.com